Novo Nordisk CEO on earnings: Very bullish on 2025 despite demand concerns

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins 'Money Movers' to discuss Jorgensen's comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

Related Posts

Axon and Skydio CEOs talk partnership developing first ...

admin Aug 10, 2024  0  6

Dominon Energy CEO weighs in on deal with Amazon to dev...

admin Oct 22, 2024  0  9

Rubrik CEO Bipul Sinha talks Q2 results

admin Sep 10, 2024  0  21

Comments

Name

Email

Comment

Post Comment